These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36529037)

  • 41. Solid dispersion of hydroxypropyl beta-cyclodextrin and ketorolac: enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats.
    Nagarsenker MS; Meshram RN; Ramprakash G
    J Pharm Pharmacol; 2000 Aug; 52(8):949-56. PubMed ID: 11007065
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biological activity of water-soluble inclusion complexes of 1'-acetoxychavicol acetate with cyclodextrins.
    Azuma H; Aizawa Y; Higashitani N; Tsumori T; Kojima-Yuasa A; Matsui-Yuasa I; Nagasaki T
    Bioorg Med Chem; 2011 Jun; 19(12):3855-63. PubMed ID: 21596572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.
    Dudhipala N; Ettireddy S; Youssef AAA; Puchchakayala G
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Spectroscopic study and antioxidant properties of the inclusion complexes of rosmarinic acid with natural and derivative cyclodextrins.
    Celik SE; Ozyürek M; Tufan AN; Güçlü K; Apak R
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 May; 78(5):1615-24. PubMed ID: 21377406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Optimization of sulfobutyl-ether-β-cyclodextrin levels in oral formulations to enhance progesterone bioavailability.
    Shankar VK; Police A; Pandey P; Cuny ZG; Repka MA; Doerksen RJ; Murthy SN
    Int J Pharm; 2021 Mar; 596():120212. PubMed ID: 33493605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
    Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
    Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetic study of solid-lipid-nanoparticles of altretamine complexed epichlorohydrin-β-cyclodextrin for enhanced solubility and oral bioavailability.
    Gidwani B; Vyas A
    Int J Biol Macromol; 2017 Aug; 101():24-31. PubMed ID: 28315435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
    Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
    Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Formulation and hypoglycemic activity of pioglitazone-cyclodextrin inclusion complexes.
    Elbary AA; Kassem MA; Abou Samra MM; Khalil RM
    Drug Discov Ther; 2008 Apr; 2(2):94-107. PubMed ID: 22504505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Solubilization of vorinostat by cyclodextrins.
    Cai YY; Yap CW; Wang Z; Ho PC; Chan SY; Ng KY; Ge ZG; Lin HS
    J Clin Pharm Ther; 2010 Oct; 35(5):521-6. PubMed ID: 20831676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclodextrin-based nanosponges for delivery of resveratrol: in vitro characterisation, stability, cytotoxicity and permeation study.
    Ansari KA; Vavia PR; Trotta F; Cavalli R
    AAPS PharmSciTech; 2011 Mar; 12(1):279-86. PubMed ID: 21240574
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
    Mashaqbeh H; Obaidat R; Al-Shar'i N
    Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An optimized commercially feasible milling technique for molecular encapsulation of meloxicam in β-cyclodextrin.
    Bandarkar FS; Vavia PR
    Drug Dev Ind Pharm; 2011 Nov; 37(11):1318-28. PubMed ID: 21506882
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydrophilic and hydrophobic cyclodextrins in a new sustained release oral formulation of nicardipine: in vitro evaluation and bioavailability studies in rabbits.
    Fernandes CM; Ramos P; Falcão AC; Veiga FJ
    J Control Release; 2003 Feb; 88(1):127-34. PubMed ID: 12586510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations.
    Buchanan CM; Buchanan NL; Edgar KJ; Klein S; Little JL; Ramsey MG; Ruble KM; Wacher VJ; Wempe MF
    J Pharm Sci; 2007 Nov; 96(11):3100-16. PubMed ID: 17712849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlled Release, Intestinal Transport, and Oral Bioavailablity of Paclitaxel Can be Considerably Increased Using Suitably Tailored Pegylated Poly(Anhydride) Nanoparticles.
    Calleja P; Espuelas S; Vauthier C; Ponchel G; Irache JM
    J Pharm Sci; 2015 Sep; 104(9):2877-86. PubMed ID: 25600579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyclodextrin-based nanosponges as promising carriers for active agents.
    Allahyari S; Trotta F; Valizadeh H; Jelvehgari M; Zakeri-Milani P
    Expert Opin Drug Deliv; 2019 May; 16(5):467-479. PubMed ID: 30845847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique.
    Zu Y; Wu W; Zhao X; Li Y; Wang W; Zhong C; Zhang Y; Zhao X
    Int J Pharm; 2014 Aug; 471(1-2):366-76. PubMed ID: 24882039
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro and in vivo studies on the complexes of vinpocetine with hydroxypropyl-beta-cyclodextrin.
    Nie S; Fan X; Peng Y; Yang X; Wang C; Pan W
    Arch Pharm Res; 2007 Aug; 30(8):991-1001. PubMed ID: 17879753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cyclodextrin-Based Nanosponges: Overview and Opportunities.
    Utzeri G; Matias PMC; Murtinho D; Valente AJM
    Front Chem; 2022; 10():859406. PubMed ID: 35402388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.